• Complex Peripheral Vascular Interventions (SCAI-CPVI)

    Wednesday, May 10, 2017 | 7:00 AM - 11:00 AM

    Hilton New Orleans Riverside, Grand Ballroom D, 1st Level
    Two Poydras Street
    New Orleans, LA

    Sponsored by SCAI

    Supported by BARD, Boston Scientific, Cook Medical, and Terumo

    Learning Objectives

    • Review strategies for clinical and non-invasive assessment of patients with LE PVD, and strategies for medical optimization.
    • Determine patient candidacy and appropriateness for revascularization of LE PVD, including a discussion of indications and contraindications.
    • Identify the most effective mode of revascularization based on patient- and lesion-specific factors:
    • Endovascular vs. surgical therapy
    • Location of lesion(iliac, femoropopliteal, infrapopliteal zones)
    • Lesion length
    • Other anatomic considerations (inflow, outflow, presence and location of collaterals)
    • Establish strategies for preprocedural planning, including the use of non-invasive imaging modalities to guide access choices:
      • Femoral, brachial, radial, popliteal, pedal, or other
      • Antegrade vs. retrograde
      • Strategy for obtaining access
    • Describe the techniques and tools available for successful crossing of complex lesions
    • Discuss current endovascular treatment options for treatment of complex lower extremity PAD.
    • Discuss the role for hybrid revascularization strategies
    • Review strategies for longitudinal management and medical optimization following lower extremity reconstruction, with a focus on team-based care.
    • Review appropriate wound care and indications for limited or major amputations
    • Discuss the impact of operator clinical and technical experience on case selection for complex endovascular therapy: focus on graduated progression in case complexity; collaboration with colleagues; proctoring; tools for acquiring greater experience; and strategies to promote the use of appropriate discretion.
    • Highlight how to avoid and manage complications


    Time (CT)



    7:00 AM Introduction to Workshop Strategy and Objectives Douglas E. Drachman, MD, FSCAI; Sahil A. Parikh, MD, FSCAI
    7:20 AM Case Presentation 1: Iliac Sahil A. Parikh, MD, FSCAI
    7:30 AM Case Presentation 2: Superficial Femoral Artery Douglas E. Drachman, MD, FSCAI
    7:40 AM Presentation of CASE 3 Critical Limb Ischemia (CLI) Mehdi Shishehbor, DO, FSCAI
    7:50 AM Discussion - Attendees in 3 Groups  
    8:30 AM Presentations of Prospective Strategies by Workgroups  
    9:20 AM Access Considerations in Aorto-Iliac Intervention: Ipsilateral, Contralateral, or Bilateral Retrograde CFA Access? When to Consider Brachial or Radial Access? Douglas E. Drachman, MD, FSCAI
    9:35 AM Complex Aorto-Iliac Intervention: CTO/TASC D, Bifurcation Disease, Covered Stents Ehrin J. Armstrong, MD, MSc, MAS, FSCAI
    9:50 AM Access Selection: Antegrade vs. Retrograde “Up and Over.” Is Radial an Option? Transpedal/Tibial Access Douglas E. Drachman, MD, FSCAI
    10:05 AM CTO Strategies for the SFA: Popliteal Segment Mehdi Shishehbor, DO, FSCAI
    10:20 AM Atherectomy? Balloon? Cutting Balloon? DES/DCB? Excimer Laser? An Alphabet Soup of Options for the SFA: Which is Best for My Patients?  Sahil A. Parikh, MD, FSCAI
    10:40 AM Complications Potpourri Sahil A. Parikh, MD, FSCAI


    Accreditation Statement

    The Society for Cardiovascular Angiography and Interventions is accredited by the ACCME to provide continuing medical education for physicians.

    Certification Statement

    The Society for Cardiovascular Angiography and Interventions designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Disclosure Information

    As part of SCAI’s ACCME compliance activities, SCAI collects disclosure information from all faculty and staff members indicating relevant financial relationships with commercial interests. Faculty disclosure information will be made known to the participants prior to the activity. No SCAI staff member disclosed any financial relationships with any commercial interest for the year 2016. All the conflicts were resolved before the activity. The content was peer reviewed for medical accuracy, fair balance, and non-bias.